These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26896783)

  • 1. Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
    Alroughani R; Ashkanani A; Al-Hashel J; Khan R; Thussu A; Alexander KJ; Vembu P; Sharfuddin K; Lamdhade S; John JK; Alkhashan S; Abualmelh M; Al-Shammri S
    Clin Neurol Neurosurg; 2016 Apr; 143():51-64. PubMed ID: 26896783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.
    Marques VD; Passos GRD; Mendes MF; Callegaro D; Lana-Peixoto MA; Comini-Frota ER; Vasconcelos CCF; Sato DK; Ferreira MLB; Parolin MKF; Damasceno A; Grzesiuk AK; Muniz A; Matta APDC; Oliveira BES; Tauil CB; Maciel DRK; Diniz DS; Corrêa EC; Coronetti F; Jorge FMH; Sato HK; Gonçalves MVM; Sousa NAC; Nascimento OJM; Gama PDD; Domingues R; Simm RF; Thomaz RB; Morales RR; Dias RM; Apóstolos-Pereira SD; Machado SCN; Junqueira TF; Becker J
    Arq Neuropsiquiatr; 2018 Aug; 76(8):539-554. PubMed ID: 30231128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring.
    Traboulsee A; Létourneau-Guillon L; Freedman MS; O'Connor PW; Bharatha A; Chakraborty S; Girard JM; Giuliani F; Lysack JT; Marriott JJ; Metz LM; Morrow SA; Oh J; Sharma M; Vandorpe RA; Vertinsky TA; Wadhwa VS; von Riedemann S; Li DK
    Can J Neurol Sci; 2015 May; 42(3):159-67. PubMed ID: 25896163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus recommendations on the management of multiple sclerosis patients in Argentina.
    Cristiano E; Rojas JI; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Curbelo MC; Deri N; Fernandez Liguori N; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Luetic GG; Maglio I; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Tkachuk V; Villa A; Vrech C; Ysrraelit MC; Correale J
    J Neurol Sci; 2020 Feb; 409():116609. PubMed ID: 31816524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E;
    J Clin Neurosci; 2014 Nov; 21(11):1857-65. PubMed ID: 24993136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
    Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; Gerevini S; Meroni L; Origoni M; Prosperini L; Puoti M; Scarpazza C; Tortorella C; Zaffaroni M; Riva A
    Mult Scler; 2021 Mar; 27(3):331-346. PubMed ID: 32940121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diagnosis and early treatment on the course of multiple sclerosis.
    Noyes K; Weinstock-Guttman B
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s321-31. PubMed ID: 24494633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
    Happe LE
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s332-42. PubMed ID: 24494634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS).
    Yamout B; Alroughani R; Al-Jumah M; Goueider R; Dahdaleh M; Inshasi J; Hashem S; Alsharoqi I; Sahraian M; Khoury S; Alkawi Z; Koussa S; Zakaria M; Al Khaburi J; Alsaadi T; Bohlega S
    Curr Med Res Opin; 2015; 31(7):1349-61. PubMed ID: 25946578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in multiple sclerosis care: Results from an international mixed-methods study.
    Péloquin S; Schmierer K; Leist TP; Oh J; Murray S; Lazure P
    Mult Scler Relat Disord; 2021 May; 50():102854. PubMed ID: 33690086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSN MS guidelines for the management of multiple sclerosis.
    Shatila AR; Koussa S; Jabbour R; Mourad A; Aouad A; Sabbagh G; Kallab K; Hilal R; Khalifeh R; Gebeily S; Tourbah A;
    Rev Neurol (Paris); 2013 Dec; 169(12):950-5. PubMed ID: 23434141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk evaluation and monitoring in multiple sclerosis therapeutics.
    Clanet MC; Wolinsky JS; Ashton RJ; Hartung HP; Reingold SC
    Mult Scler; 2014 Sep; 20(10):1306-11. PubMed ID: 24293456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
    Freedman MS; Devonshire V; Duquette P; Giacomini PS; Giuliani F; Levin MC; Montalban X; Morrow SA; Oh J; Rotstein D; Yeh EA;
    Can J Neurol Sci; 2020 Jul; 47(4):437-455. PubMed ID: 32654681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric multiple sclerosis: a review.
    Alroughani R; Boyko A
    BMC Neurol; 2018 Mar; 18(1):27. PubMed ID: 29523094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.
    Alroughani R; Ahmed SF; Behbehani R; Al-Hashel J
    Clin Neurol Neurosurg; 2014 Apr; 119():17-20. PubMed ID: 24635919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E;
    J Clin Neurosci; 2014 Nov; 21(11):1835-46. PubMed ID: 24993135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines.
    Yamout B; Sahraian M; Bohlega S; Al-Jumah M; Goueider R; Dahdaleh M; Inshasi J; Hashem S; Alsharoqi I; Khoury S; Alkhawajah M; Koussa S; Al Khaburi J; Almahdawi A; Alsaadi T; Slassi E; Daodi S; Zakaria M; Alroughani R
    Mult Scler Relat Disord; 2020 Jan; 37():101459. PubMed ID: 31670208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
    De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.